Aster Capital Management (Difc) LTD Kura Oncology, Inc. Call Options Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KURA
# of Institutions
193Shares Held
77.5MCall Options Held
103KPut Options Held
106K-
Black Rock Inc. New York, NY6.97MShares$57.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$47.9 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$41.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.7 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $552M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...